From January 27 to 30, 2025, the 50th edition of Arab Health Exhibition and Congress, a flagship event in the global healthcare industry, concluded successfully at the Dubai World Trade Centre. Jining Jianda Medical Device Technology Co., Ltd., a Shandong-provincial specialized, refined, featured, and innovative SME, made a stunning appearance with its dual-line products of high-end medical equipment and core consumables, emerging as a representative enterprise with both technical depth and market potential in the Chinese exhibition group.
Marking its 50th anniversary milestone, this year's exhibition attracted over 4,000 enterprises from more than 100 countries worldwide, including 710 Chinese companies, and received over 60,000 professional visitors, hitting a record high. Adopting the core strategy of "technological breakthrough + local adaptation", Jining Jianda showcased two major product lines: the domestically pioneered Deep Spectrum Therapeutic Apparatus that breaks the monopoly of high-end imported products, providing innovative solutions for wound repair and pain management with internationally advanced spectral penetration technology; and disposable medical consumables such as anesthetic puncture kits and self-adhesive wound dressings, whose original anti-falling catheter design solves long-standing industry pain points in clinical operations. All products are manufactured in 100,000-class clean workshops and certified by the ISO13485 international quality system, perfectly meeting the Middle East market's dual demands for high-end medical equipment and high-safety consumables.
During the exhibition, Jining Jianda's booth maintained high popularity, receiving over 150 potential clients from Saudi Arabia, the UAE, Kuwait and other countries. It reached preliminary cooperation intentions with 8 renowned medical institutions including Saudi Arabia's Al Rahba Hospital and the UAE's NMC Healthcare, and signed framework agreements with 3 top local agents, with the first batch of orders expected to exceed 8 million yuan. "Driven by the 'Vision 2030', the Middle East has seen annual growth of over 15% in medical infrastructure investment, creating an urgent demand for cost-effective medical products that can replace imports," said Zhang Xiao, General Manager of Jining Jianda. He added that the participation is an important measure to respond to the "Belt and Road" Initiative, demonstrating the technical strength of Chinese medical equipment to the Middle East market through this global platform.
Customs data shows that China's medical device exports to Saudi Arabia increased by 26.24% year-on-year in 2024, making the Middle East a core growth market for Chinese medical enterprises going global. In the future, Jining Jianda will upgrade the high-temperature resistance and stability of its consumables to adapt to the Middle East's climatic characteristics, and plans to establish a regional service center in Dubai to build a 48-hour rapid response system with local partners, contributing to the upgrading of regional medical equipment.
